To use this site, please disable the ad blocking feature and reload the page.
This website uses cookies to collect information about your visit for purposes such as showing you personalized ads and content, and analyzing our website traffic. By clicking “Accept all,” you will allow the use of these cookies.
Users accessing this site from EEA countries and UK are unable to view this site without your consent. We apologize for any inconvenience caused.
Courtesy of Taiko Pharmaceutical Co. Cleverin, produced by Taiko Pharmaceutical Co.
The Yomiuri Shimbun
17:47 JST, April 11, 2023
Taiko Pharmaceutical Co. has been ordered to pay a record surcharge of more than ¥600 million for claiming one of its products could disinfect bacteria in the air. The Consumer Affairs Agency on Tuesday said that the company violated the Law against Unjustifiable Premiums and Misleading Representation in advertisements for Cleverin, its bacteria disinfectant product. The advertisements, which claim the product can eliminate bacteria and viruses floating in the air, are groundless, says the agency.
It asserts that the company has violated the law by misleading consumers into believing that Cleverin is better than it actually is.
The surcharge is the largest ever on record for a case based on that law.
